DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 2Adcock Ingram
03 1Amgen Inc
04 1Aprogen
05 2CELLTRION INC.
06 20Celltrion
07 2CinnaGen
08 2Cipla Medpro South Africa
09 2Dr Reddy's Laboratories (Pty) Ltd
10 21F. Hoffmann-La Roche
11 4Genentech
12 2Iqone Healthcare Switzerland Sa
13 8Pfizer Consumer Healthcare
14 9Pfizer Inc
15 3Roche Diagnostics GmbH
16 21Sandoz B2B
01 10Concentrate For Infusion Solution
02 26Concentrate For Solution For Infusion
03 12INF
04 1INJ
05 5INJECTABLE;INJECTION
06 2Injectable
07 2Injectable Solution
08 1Rituximab 100Mg 10Ml 2 Units Parenteral Use
09 1Rituximab 140011,7Mg Ml 1 Units Parenteral Use
10 1Rituximab 500Mg 50Ml 1 Units Parenteral Use
11 7SOLUTION
12 2SOLUTION;INTRAVENOUS
13 2SOLUTION;SUBCUTANEOUS
14 2Solution For Injection
15 3Subcutaneous Injectable Solution
16 25Blank
01 12Allowed
02 16Approved
03 11Authorized
04 4Deregistered
05 10Generic
06 3Originator
07 6Prescription
08 1Schedule D
09 39Blank
01 1BLITZIMA 100 mg
02 1BLITZIMA 500 mg
03 2Blitzima
04 2Ituxredi
05 1MABTHERA SC 1400mg
06 2MabThera
07 2MabThera subcutaneous
08 10Mabthera
09 1Mabthera 100Mg 10Ml
10 1Mabthera 500Mg 50Ml
11 1RIABNI
12 1RISTOVA® 100
13 1RISTOVA® 500
14 3RITUXAN
15 2RITUXAN HYCELA
16 2RITUXAN SC
17 1RIXIMYO
18 3RUXIENCE
19 1Redditux 100
20 1Redditux 500
21 2Ristova
22 2Ritemvia
23 1Rituximab 100 Cipla
24 1Rituximab 500 Cipla
25 2Rituzena
26 6Rixathon
27 1Rixathon 100mg/10ml
28 1Rixathon 500mg/50ml
29 12Riximyo
30 14Ruxience
31 4TRUXIMA
32 14Truxima
33 2Zytux
34 1Blank
01 24Australia
02 7Canada
03 2Iran
04 3Italy
05 13South Africa
06 1South Korea
07 11Spain
08 20Sweden
09 12Switzerland
10 9USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Ituxredi
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 100mg
Packaging :
Approval Date : 19/09/2024
Application Number : 20230426000122
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Ituxredi
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 500mg
Packaging :
Approval Date : 19/09/2024
Application Number : 20230426000139
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info :
Registration Country : USA
Brand Name : RIABNI
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 100MG/10ML(10MG/ML)
Packaging :
Approval Date :
Application Number : 761140
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : South Korea
Brand Name :
Dosage Form :
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Regulatory Info :
Registration Country : USA
Brand Name : TRUXIMA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 100MG/10ML(10MG/ML)
Packaging :
Approval Date :
Application Number : 761088
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : TRUXIMA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 500MG/50ML(10MG/ML)
Packaging :
Approval Date :
Application Number : 761088
Regulatory Info :
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Blitzima
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 100mg
Packaging :
Approval Date : 30/11/2017
Application Number : 20171219000038
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Blitzima
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 500mg
Packaging :
Approval Date : 13/07/2017
Application Number : 20170307000011
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info :
Registration Country : Iran
Brand Name : Zytux
Dosage Form : Injectable
Dosage Strength : 100MG
Packaging : Vial
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : Iran
Brand Name : Zytux
Dosage Form : Injectable
Dosage Strength : 500MG
Packaging : Vial
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : Italy
Brand Name : Mabthera
Dosage Form : Rituximab 100Mg 10Ml 2 Units Parenteral Use
Dosage Strength : 2 VIALS EV 100 mg 10 ml 10 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Mabthera
Dosage Form : Rituximab 500Mg 50Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 500 mg 50 ml 10 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Mabthera
Dosage Form : Rituximab 140011,7Mg Ml 1 Units Parenteral Use
Dosage Strength : 1 vial SC 1,400 mg/11.7 ml 15 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Mabthera
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 100mg
Packaging :
Approval Date : 02/06/1998
Application Number : 19980602000012
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info :
Registration Country : USA
Brand Name : RITUXAN
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 100MG/10ML (10MG/ML)
Packaging :
Approval Date :
Application Number : 103705
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RITUXAN
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 500MG/50ML (10MG/ML)
Packaging :
Approval Date :
Application Number : 103705
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT)
Brand Name : RITUXAN HYCELA
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 1400MG and 23400UNITS/11.7ML
Packaging :
Approval Date :
Application Number : 761064
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT)
Brand Name : RITUXAN HYCELA
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 1600MG and 26800UNITS/13.4ML
Packaging :
Approval Date :
Application Number : 761064
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RUXIENCE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 100MG/10ML(10MG/ML)
Packaging :
Approval Date :
Application Number : 761103
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RUXIENCE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 500MG/50ML(10MG/ML)
Packaging :
Approval Date :
Application Number : 761103
Regulatory Info :
Registration Country : USA
